News and Updates

Make in India: Can India be a hub for the $200 billion worth biosimilars opportunity

17/10/2016
By HARI PULAKKAT, ET Bureau | Updated: Feb 18, 2016 The Indian generics industry got its first big break in 1984, when the US passed what is known as the Hatch-Waxman Act. With this legislation, the...

India Pharma Inc gears up for CPhI & P-MEC India 2015​

27/01/2016
Press release India Pharma Inc gears up for CPhI & P-MEC India 2015​

UBM India launches CPhI & P-MEC India 2015

27/01/2016
Press release UBM India launches CPhI & P-MEC India 2015